INTRATHECAL ADMINISTRATION OF HIGH-DOSE MORPHINE SOLUTIONS DECREASES THE PH OF CEREBROSPINAL-FLUID

Citation
Mfm. Wagemans et al., INTRATHECAL ADMINISTRATION OF HIGH-DOSE MORPHINE SOLUTIONS DECREASES THE PH OF CEREBROSPINAL-FLUID, Pain, 61(1), 1995, pp. 55-59
Citations number
40
Categorie Soggetti
Neurosciences
Journal title
PainACNP
ISSN journal
03043959
Volume
61
Issue
1
Year of publication
1995
Pages
55 - 59
Database
ISI
SICI code
0304-3959(1995)61:1<55:IAOHMS>2.0.ZU;2-M
Abstract
Terminally ill patients suffering from intractable cancer pain are tre ated in our hospital on an outpatient basis with a percutaneous intrat hecal (i.t.) catheter and a portable pump delivering morphine continuo usly. In a patient showing an increased demand of morphine the dose wa s raised from 1.5 to 2 mg/h, but pain intensity did not decrease. Subs equently a 1.5 ml dose of 5% lidocaine was administered; however, no m otor or sensory block was observed. After controlling the catheter pos ition and passage through the catheter, a sample of cerebrospinal flui d (CSF) was taken and the pH was measured. It was found to be outside the physiological range of 7.19 (normal range: 7.27-7.37), possibly ex plaining the decreased activity of the local anesthetic. The purpose o f this study was to determine the influence of morphine, with or witho ut sodium metabisulfite, on pH in vitro, using artificial CSF (ACSF) a nd on pH in vivo during i.t. administration of morphine. An in vitro m odel was used to measure pH changes by adding a morphine solution (con centrations of 0.5, 2, 5 and 10 mg/ml) with and without sodium metabis ulfite to ACSF solutions (Elliott B). Fourteen patients were consecuti vely selected for continuous administration of morphine. An i.t. cathe ter was inserted, tunnelled and connected with an external pump (Provi der 5500, Abbott, Chicago, IL). CSF was aspirated and pH was measured with a blood-gas system (Ciba-Corning 288, Medfield, USA). In vitro, m orphine solutions with or without sodium metabisulfite added to an Ell iott B solution (pH = 7.47, 37 degrees C) caused a concentration-relat ed decrease in pH. In vivo, in 9 patients, the daily morphine dose was less than 24 mg and the range of the CSF pH was between 7.25 and 7.44 . In 5 patients, the daily morphine dose was higher than 24 mg and the CSF pH ranged from 6.92 to 7.24. In 4 patients myoclonic seizures and an increase in pain were observed. Our study suggests that long-term i.t. administration of high-dose morphine solutions with or without so dium metabisulfite may decrease the pH of CSF outside the normal range of 7.27-7.37. This may explain the diminished effectiveness of i.t. a dministered local anesthetics and morphine due to the increase of the ionized part of the available drug. Buffer capacity of CSF is insuffic ient to maintain normal pH values in patients receiving high doses of morphine solutions. A more neutral morphine formulation may be necessa ry for i.t. use.